We are live on ! Find out more
LAB icon

Standard BioTools
LAB

145 hedge funds and large institutions have $391M invested in Standard BioTools in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $5.23M | Put options by funds: $2.6M

69% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 32

41% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 27

8% more funds holding

Funds holding: 134 → 145 (+11)

4.66% less ownership

Funds ownership: 92.76% → 88.1% (-4.7%)

17% less capital invested

Capital invested by funds: $472M → $391M (-$80.9M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
145
Holders Change
+11
Holders Change %
+8.21%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
38
Increased
54
Reduced
32
Closed
27
Calls
$5.23M
Puts
$2.6M
Net Calls
+$2.63M
Net Calls Change
-$2.6M

Top Buyers

1
ICM
Indaba Capital Management
California
+$10.3M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.84M
3
ACM
Asymmetry Capital Management
California
+$3.72M
4
PCMI
Paradigm Capital Management Inc
New York
+$3.56M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.45M

Top Sellers

1
Invesco
Invesco
Georgia
-$13.8M
2
EP
Eversept Partners
New York
-$9.68M
3
Renaissance Technologies
Renaissance Technologies
New York
-$9.61M
4
Millennium Management
Millennium Management
New York
-$9.26M
5
PVI
Pura Vida Investments
New York
-$6.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
151
Schonfeld Strategic Advisors
New York
– -$1.56M -210,600 Closed
Group One Trading
152
Group One Trading
Illinois
– -$882K -134,214 Closed
Russell Investments Group
153
Russell Investments Group
United Kingdom
– -$788K -106,289 Closed
PGCM
154
Prescott Group Capital Management
Oklahoma
– -$721K -97,000 Closed
JIP
155
Jaffetilchin Investment Partners
Florida
– -$328K -44,208 Closed
AAP
156
Ardsley Advisory Partners
Connecticut
– -$223K -30,000 Closed
Simplex Trading
157
Simplex Trading
Illinois
– -$196K -29,761 Closed
American Century Companies
158
American Century Companies
Missouri
– -$204K -27,471 Closed
PP
159
Paloma Partners
Connecticut
– -$197K -26,467 Closed
SO
160
STRS Ohio
Ohio
– -$170K -23,000 Closed
SFI
161
Susquehanna Fundamental Investments
Pennsylvania
– -$121K -16,300 Closed
BCM
162
Bayesian Capital Management
New York
– -$114K -15,300 Closed
SIM
163
Spark Investment Management
New York
– -$105K -14,200 Closed
EIP
164
Easterly Investment Partners
Massachusetts
– -$96K -12,986 Closed
Commonwealth Equity Services
165
Commonwealth Equity Services
Massachusetts
– -$78K -10,571 Closed
FRM
166
Fox Run Management
Connecticut
– -$75K -10,101 Closed
WMSA
167
Weiss Multi-Strategy Advisers
New York
– -$74K -10,000 Closed
PFS
168
Prospera Financial Services
Texas
– -$5K -640 Closed
SFS
169
Sowell Financial Services
Arkansas
– -$3K -400 Closed
AA
170
Advisory Alpha
Michigan
– -$1K -158 Closed
HCM
171
Horrell Capital Management
Arkansas
– -$1K -100 Closed
EI
172
Ellevest Inc
New York
– +$66 +10 New
3 4 5 6
7

LAB Hedge Fund Activity: Q4 2020 in Review

145 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2020, worth a combined $391M — down 17% from $472M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new LAB positions and 27 closed out — a net gain of 11 holders — while 54 added to existing stakes and 32 trimmed.

The largest buyer was Indaba Capital Management, adding an estimated $10.3M. The largest seller was Invesco, cutting an estimated $13.8M.

  • 145 institutional investors held Standard BioTools (LAB) as of Q4 2020, up from 134 in Q3 2020.
  • Funds reported $391M of Standard BioTools stock for Q4 2020, down 17% quarter-over-quarter.
  • 38 funds opened new Standard BioTools positions in Q4 2020 and 27 closed out, a net change of +11 holders.
  • The largest Standard BioTools buyer in Q4 2020 was Indaba Capital Management, an estimated $10.3M added.
  • The largest Standard BioTools seller in Q4 2020 was Invesco, an estimated $13.8M sold.

Based on aggregated 13F filings for Q4 2020.